Investors in Acadia Pharmaceuticals Inc. ACAD need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 20, 2024 $29 Call had some of the highest implied...
March S&P 500 E-Mini futures (ESH24) are trending up +0.30% this morning as market participants awaited the all-important U.S. consumer inflation report that could shed light on the Federal Reserve’s...
An analyst upgrade is sparking a rally in the drugmaker's shares today.
These two growth stocks could be worthwhile buy-and-holds.
A top hedge fund has been steadily buying these two growth stocks in 2023.
Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...